It was one of the riddles of early insulin-like growth factor (IGF) (5) and ultrafiltration by centrifugation (6). The latter method works under conditions close to those in vivo (temperature, pH and ionic milieu) and thus probably maintains the physiological equilibrium between free and bound IGF. With the first two methods, mean free IGF-I levels of 2-4 ± 0-1 (s.e.m.) and l-3± 0-54ng/ml (s.d.) respectively (1-5 ± 0-1 and 0-71± 0-36% of total IGF-I) have been reported in normal human serum. With the ultrafiltration method, between 0-41 and 0-95 ng/ml (age-dependent) is detected as free IGF-I (0-38 ± 0-02% of total IGF-I) and l-48±0-08 ng/ ml) (not age-dependent) as free IGF-II (0-2 ± 0-01% of total IGF-II).
potential of circulating IGF by far exceeded that of fasting serum insulin levels without obvious effects on glucose homeostasis. The total serum level of IGF-I and -II in normal adults, but also in insulin-deficient diabetic patients, lies around 1 \g=m\g/ml, which corresponds to an insulin-like activity of 200\p=n-\300 \g=m\U/ml of insulin equivalents (1) . This insulin-like potential would be expected to cause permanent hypoglycemia and should prevent diabetes. The (5) and ultrafiltration by centrifugation (6) . The latter method works under conditions close to those in vivo (temperature, pH and ionic milieu) and thus probably maintains the physiological equilibrium between free and bound IGF. With the first two methods, mean free IGF-I levels of 2-4 ± 0-1 (s.e.m.) and l-3± 0-54ng/ml (s.d.) respectively (1-5 ± 0-1 and 0-71± 0-36% of total IGF-I) have been reported in normal human serum. With the ultrafiltration method, between 0-41 and 0-95 ng/ml (age-dependent) is detected as free IGF-I (0-38 ± 0-02% of total IGF-I) and l-48±0-08 ng/ ml) (not age-dependent) as free IGF-II (0-2 ± 0-01% of total IGF-II).
As judged from the affinity of the type 1 IGF receptor for IGF-I (Kd~1 0"9 mol/1) and for IGF-II (which acts through the type 1 IGF receptor but has a lower affinity), free IGF-I and -II levels as determined by ultrafiltration (0-05-0-13 and 0-2 10"9 mol/1 respec¬ tively) might elicit borderline effects via the type 1 IGF receptor. However, in mouse and rat skeletal muscle where IGF-I stimulates glucose metabolism through its own receptor, half-maximal effects were observed between 3 and 10nmol/1 (23-75 ng/ml) (7, 8 Administration of exogenous IGF may lower blood sugar levels depending on the administered dose. In normal human subjects infused with 10^g IGF-I/kg per h for several days, fasting plasma glucose levels fell from 4-7 ± 0-3 to 4-3 ± 0-3 mmol/1, which was a statistically significant change (10) . Free IGF-I rose from basal levels of 0-óng/ml (0-08nmol/1) to 11-lng/ml (l-5nmol/l) (11 
